Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 84

1.

Advanced stage breast cancer is associated with catheter-tip thrombus formation following implantable central venous port placement.

Makary MS, Lionberg A, Khayat M, Lustberg MB, AlTaani J, Pan XJ, Layman RR, Raman SV, Layman RM, Dowell JD.

Phlebology. 2018 Jan 1:268355518774442. doi: 10.1177/0268355518774442. [Epub ahead of print]

PMID:
29771187
2.

Complete and durable responses in Primary Central Nervous System Post-Transplant Lymphoproliferative Disorder with Zidovudine, Ganciclovir, Rituximab and Dexamethasone.

Dugan JP, Haverkos BM, Villagomez L, Martin L, Lustberg ME, Patton JT, Martin M, Huang Y, Nuovo G, Yan F, Cavaliere R, Fingeroth JD, Kenney SC, Ambinder RF, Lozanski G, Porcu P, Caligiuri MA, Baiocchi RA.

Clin Cancer Res. 2018 Apr 9. pii: clincanres.2685.2017. doi: 10.1158/1078-0432.CCR-17-2685. [Epub ahead of print]

PMID:
29632007
3.

Implementing Liquid Biopsies in Clinical Trials: State of Affairs, Opportunities, and Challenges.

Lustberg MB, Stover DG, Chalmers JJ.

Cancer J. 2018 Mar/Apr;24(2):61-64. doi: 10.1097/PPO.0000000000000309.

PMID:
29601331
4.

Disparities in breast cancer tumor characteristics, treatment, time to treatment, and survival probability among African American and white women.

Foy KC, Fisher JL, Lustberg MB, Gray DM, DeGraffinreid CR, Paskett ED.

NPJ Breast Cancer. 2018 Mar 20;4:7. doi: 10.1038/s41523-018-0059-5. eCollection 2018.

5.

Usefulness of Integrating Heart Failure Risk Factors Into Impairment of Global Longitudinal Strain to Predict Anthracycline-Related Cardiac Dysfunction.

Milks MW, Velez MR, Mehta N, Ishola A, Van Houten T, Yildiz VO, Reinbolt R, Lustberg M, Smith SA, Orsinelli DA.

Am J Cardiol. 2018 Apr 1;121(7):867-873. doi: 10.1016/j.amjcard.2017.12.022. Epub 2018 Jan 12.

PMID:
29454478
6.

OATP1B2 deficiency protects against paclitaxel-induced neurotoxicity.

Leblanc AF, Sprowl JA, Alberti P, Chiorazzi A, Arnold WD, Gibson AA, Hong KW, Pioso MS, Chen M, Huang KM, Chodisetty V, Costa O, Florea T, de Bruijn P, Mathijssen RH, Reinbolt RE, Lustberg MB, Sucheston-Campbell LE, Cavaletti G, Sparreboom A, Hu S.

J Clin Invest. 2018 Feb 1;128(2):816-825. doi: 10.1172/JCI96160. Epub 2018 Jan 16.

7.

Diet Quality, Inflammation, and Quality of Life in Breast Cancer Survivors: A Cross-Sectional Analysis of Pilot Study Data.

Orchard TS, Andridge RR, Yee LD, Lustberg MB.

J Acad Nutr Diet. 2018 Apr;118(4):578-588.e1. doi: 10.1016/j.jand.2017.09.024. Epub 2017 Dec 9.

PMID:
29233615
8.

Genomic risk prediction of aromatase inhibitor-related arthralgia in patients with breast cancer using a novel machine-learning algorithm.

Reinbolt RE, Sonis S, Timmers CD, Fernández-Martínez JL, Cernea A, de Andrés-Galiana EJ, Hashemi S, Miller K, Pilarski R, Lustberg MB.

Cancer Med. 2018 Jan;7(1):240-253. doi: 10.1002/cam4.1256. Epub 2017 Nov 23.

9.

Randomized placebo-controlled pilot trial of omega 3 fatty acids for prevention of aromatase inhibitor-induced musculoskeletal pain.

Lustberg MB, Orchard TS, Reinbolt R, Andridge R, Pan X, Belury M, Cole R, Logan A, Layman R, Ramaswamy B, Wesolowski R, Berger M, Patterson E, Loprinzi C, Shapiro CL, Yee L.

Breast Cancer Res Treat. 2018 Feb;167(3):709-718. doi: 10.1007/s10549-017-4559-z. Epub 2017 Nov 3.

PMID:
29101597
10.

Kaposi sarcoma: An unconventional cause of lower extremity lymphedema.

Dean SM, Kaffenberger BH, Lustberg ME.

Vasc Med. 2017 Dec;22(6):544. doi: 10.1177/1358863X17729031. Epub 2017 Sep 6. No abstract available.

PMID:
28875759
11.

Multispectral Imaging Analysis of Circulating Tumor Cells in Negatively Enriched Peripheral Blood Samples.

Miller B, Lustberg M, Summers TA, Chalmers JJ.

Methods Mol Biol. 2017;1634:219-234. doi: 10.1007/978-1-4939-7144-2_19.

PMID:
28819855
12.

Circulating myeloid-derived suppressor cells increase in patients undergoing neo-adjuvant chemotherapy for breast cancer.

Wesolowski R, Duggan MC, Stiff A, Markowitz J, Trikha P, Levine KM, Schoenfield L, Abdel-Rasoul M, Layman R, Ramaswamy B, Macrae ER, Lustberg MB, Reinbolt RE, Mrozek E, Byrd JC, Caligiuri MA, Mace TA, Carson WE 3rd.

Cancer Immunol Immunother. 2017 Nov;66(11):1437-1447. doi: 10.1007/s00262-017-2038-3. Epub 2017 Jul 7.

PMID:
28688082
13.

Gait, balance, and patient-reported outcomes during taxane-based chemotherapy in early-stage breast cancer patients.

Monfort SM, Pan X, Patrick R, Ramaswamy B, Wesolowski R, Naughton MJ, Loprinzi CL, Chaudhari AMW, Lustberg MB.

Breast Cancer Res Treat. 2017 Jul;164(1):69-77. doi: 10.1007/s10549-017-4230-8. Epub 2017 Apr 3.

PMID:
28374323
14.

Multiparameter Evaluation of the Heterogeneity of Circulating Tumor Cells Using Integrated RNA In Situ Hybridization and Immunocytochemical Analysis.

Wu Y, Park KJ, Deighan C, Amaya P, Miller B, Pan Q, Zborowski M, Lustberg M, Chalmers J.

Front Oncol. 2016 Nov 8;6:234. eCollection 2016.

15.

Minocycline, a putative neuroprotectant, co-administered with doxorubicin-cyclophosphamide chemotherapy in a xenograft model of triple-negative breast cancer.

Himmel LE, Lustberg MB, DeVries AC, Poi M, Chen CS, Kulp SK.

Exp Toxicol Pathol. 2016 Oct;68(9):505-515. doi: 10.1016/j.etp.2016.08.001. Epub 2016 Aug 21.

16.

Anthracycline Cardiotoxicity: How Do We Move From Diagnosis to Prediction?

Lustberg MB, Zareba KM.

Circ Cardiovasc Imaging. 2016 Aug;9(8). pii: e005324. doi: 10.1161/CIRCIMAGING.116.005324. No abstract available.

17.

Prevention and Treatment of Cancer-Related Infections, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology.

Baden LR, Swaminathan S, Angarone M, Blouin G, Camins BC, Casper C, Cooper B, Dubberke ER, Engemann AM, Freifeld AG, Greene JN, Ito JI, Kaul DR, Lustberg ME, Montoya JG, Rolston K, Satyanarayana G, Segal B, Seo SK, Shoham S, Taplitz R, Topal J, Wilson JW, Hoffmann KG, Smith C.

J Natl Compr Canc Netw. 2016 Jul;14(7):882-913.

PMID:
27407129
18.

Natural history of postural instability in breast cancer patients treated with taxane-based chemotherapy: A pilot study.

Monfort SM, Pan X, Patrick R, Singaravelu J, Loprinzi CL, Lustberg MB, Chaudhari AMW.

Gait Posture. 2016 Jul;48:237-242. doi: 10.1016/j.gaitpost.2016.06.011. Epub 2016 Jun 14.

19.

Effects of exercise interventions during different treatments in breast cancer.

Fairman CM, Focht BC, Lucas AR, Lustberg MB.

J Community Support Oncol. 2016 May;14(5):200-9. doi: 10.12788/jcso.0225.

20.

Breast cancer and social environment: getting by with a little help from our friends.

Hinzey A, Gaudier-Diaz MM, Lustberg MB, DeVries AC.

Breast Cancer Res. 2016 May 26;18(1):54. doi: 10.1186/s13058-016-0700-x. Review.

21.

A Novel Histone Deacetylase Inhibitor, AR-42, Reactivates HIV-1 from Chronically and Latently Infected CD4+ T-cells.

Mates JM, de Silva S, Lustberg M, Van Deusen K, Baiocchi RA, Wu L, Kwiek JJ.

Retrovirology (Auckl). 2015;7:1-5. Epub 2015 Oct 15.

22.

Veliparib Alone or in Combination with Mitomycin C in Patients with Solid Tumors With Functional Deficiency in Homologous Recombination Repair.

Villalona-Calero MA, Duan W, Zhao W, Shilo K, Schaaf LJ, Thurmond J, Westman JA, Marshall J, Xiaobai L, Ji J, Rose J, Lustberg M, Bekaii-Saab T, Chen A, Timmers C.

J Natl Cancer Inst. 2016 Feb 4;108(7). doi: 10.1093/jnci/djv437. Print 2016 Jul.

23.

Risk factors for anthracycline-associated cardiotoxicity.

Reinbolt RE, Patel R, Pan X, Timmers CD, Pilarski R, Shapiro CL, Lustberg MB.

Support Care Cancer. 2016 May;24(5):2173-2180. doi: 10.1007/s00520-015-3008-y. Epub 2015 Nov 12.

24.

Biomodulation of capecitabine by paclitaxel and carboplatin in advanced solid tumors and adenocarcinoma of unknown primary.

Mikhail S, Lustberg MB, Ruppert AS, Mortazavi A, Monk P, Kleiber B, Villalona-Calero M, Bekaii-Saab T.

Cancer Chemother Pharmacol. 2015 Nov;76(5):1005-12. doi: 10.1007/s00280-015-2877-6. Epub 2015 Sep 28.

PMID:
26416564
25.

Palbociclib: A Novel Cyclin-Dependent Kinase Inhibitor for Hormone Receptor-Positive Advanced Breast Cancer.

Mangini NS, Wesolowski R, Ramaswamy B, Lustberg MB, Berger MJ.

Ann Pharmacother. 2015 Nov;49(11):1252-60. doi: 10.1177/1060028015602273. Epub 2015 Aug 31. Review.

PMID:
26324355
26.

Gene expression patterns through oral squamous cell carcinoma development: PD-L1 expression in primary tumor and circulating tumor cells.

Oliveira-Costa JP, de Carvalho AF, da Silveira da GG, Amaya P, Wu Y, Park KJ, Gigliola MP, Lustberg M, Buim ME, Ferreira EN, Kowalski LP, Chalmers JJ, Soares FA, Carraro DM, Ribeiro-Silva A.

Oncotarget. 2015 Aug 28;6(25):20902-20.

27.

Endocrine therapy in breast cancer: the neoadjuvant, adjuvant, and metastatic approach.

Reinbolt RE, Mangini N, Hill JL, Levine LB, Dempsey JL, Singaravelu J, Koehler KA, Talley A, Lustberg MB.

Semin Oncol Nurs. 2015 May;31(2):146-55. doi: 10.1016/j.soncn.2015.02.002. Epub 2015 Feb 17. Review.

PMID:
25951743
28.

Stabilization of bone marrow infiltration by metastatic breast cancer with continuous doxorubicin.

Pahouja G, Wesolowski R, Reinbolt R, Tozbikian G, Berger M, Mangini N, Lustberg MB.

Cancer Treat Commun. 2015;3:28-32.

29.

Atrophic vaginitis in breast cancer survivors: a difficult survivorship issue.

Lester J, Pahouja G, Andersen B, Lustberg M.

J Pers Med. 2015 Mar 25;5(2):50-66. doi: 10.3390/jpm5020050.

30.

The Epstein-Barr Virus Lytic Protein BZLF1 as a Candidate Target Antigen for Vaccine Development.

Hartlage AS, Liu T, Patton JT, Garman SL, Zhang X, Kurt H, Lozanski G, Lustberg ME, Caligiuri MA, Baiocchi RA.

Cancer Immunol Res. 2015 Jul;3(7):787-94. doi: 10.1158/2326-6066.CIR-14-0242. Epub 2015 Mar 3.

31.

Neoadjuvant dual HER2-targeted therapy with lapatinib and trastuzumab improves pathologic complete response in patients with early stage HER2-positive breast cancer: a meta-analysis of randomized prospective clinical trials.

Hicks M, Macrae ER, Abdel-Rasoul M, Layman R, Friedman S, Querry J, Lustberg M, Ramaswamy B, Mrozek E, Shapiro C, Wesolowski R.

Oncologist. 2015 Apr;20(4):337-43. doi: 10.1634/theoncologist.2014-0334. Epub 2015 Mar 2.

32.

Association of osteoprotegerin and bone loss after adjuvant chemotherapy in early-stage breast cancer.

Oostra DR, Lustberg MB, Reinbolt RE, Pan X, Wesolowski R, Shapiro CL.

Mol Cell Endocrinol. 2015 Feb 15;402:51-6. doi: 10.1016/j.mce.2014.12.028. Epub 2015 Jan 6.

33.

Stopping paclitaxel premedication after two doses in patients not experiencing a previous infusion hypersensitivity reaction.

Berger MJ, Vargo C, Vincent M, Shaver K, Phillips G, Layman R, Macrae E, Mrozek E, Ramaswamy B, Wesolowski R, Shapiro CL, Lustberg MB.

Support Care Cancer. 2015 Jul;23(7):2019-24. doi: 10.1007/s00520-014-2556-x. Epub 2014 Dec 18.

34.

Human leukocyte antigen type and posttransplant lymphoproliferative disorder.

Lustberg ME, Pelletier RP, Porcu P, Martin SI, Quinion CD, Geyer SM, Caligiuri MA, Baiocchi RA.

Transplantation. 2015 Jun;99(6):1220-5. doi: 10.1097/TP.0000000000000487.

PMID:
25427163
35.

The translation inhibitor silvestrol exhibits direct anti-tumor activity while preserving innate and adaptive immunity against EBV-driven lymphoproliferative disease.

Patton JT, Lustberg ME, Lozanski G, Garman SL, Towns WH, Drohan CM, Lehman A, Zhang X, Bolon B, Pan L, Kinghorn AD, Grever MR, Lucas DM, Baiocchi RA.

Oncotarget. 2015 Feb 20;6(5):2693-708.

36.

CSF1-ETS2-induced microRNA in myeloid cells promote metastatic tumor growth.

Mathsyaraja H, Thies K, Taffany DA, Deighan C, Liu T, Yu L, Fernandez SA, Shapiro C, Otero J, Timmers C, Lustberg MB, Chalmers J, Leone G, Ostrowski MC.

Oncogene. 2015 Jul;34(28):3651-61. doi: 10.1038/onc.2014.294. Epub 2014 Sep 22.

37.

A Phase II study of bevacizumab in combination with trastuzumab and docetaxel in HER2 positive metastatic breast cancer.

Zhao M, Pan X, Layman R, Lustberg MB, Mrozek E, Macrae ER, Wesolowski R, Carothers S, Puhalla S, Shapiro CL, Ramaswamy B.

Invest New Drugs. 2014 Dec;32(6):1285-94. doi: 10.1007/s10637-014-0122-5. Epub 2014 Jun 5.

38.

Management options for established chemotherapy-induced peripheral neuropathy.

Pachman DR, Watson JC, Lustberg MB, Wagner-Johnston ND, Chan A, Broadfield L, Cheung YT, Steer C, Storey DJ, Chandwani KD, Paice J, Jean-Pierre P, Oh J, Kamath J, Fallon M, Strik H, Koeppen S, Loprinzi CL.

Support Care Cancer. 2014 Aug;22(8):2281-95. doi: 10.1007/s00520-014-2289-x. Epub 2014 May 31. Review.

PMID:
24879391
39.

Treatment-related mortality with everolimus in cancer patients.

Wesolowski R, Abdel-Rasoul M, Lustberg M, Paskell M, Shapiro CL, Macrae ER.

Oncologist. 2014 Jun;19(6):661-8. doi: 10.1634/theoncologist.2013-0355. Epub 2014 May 2.

40.

Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline.

Hershman DL, Lacchetti C, Dworkin RH, Lavoie Smith EM, Bleeker J, Cavaletti G, Chauhan C, Gavin P, Lavino A, Lustberg MB, Paice J, Schneider B, Smith ML, Smith T, Terstriep S, Wagner-Johnston N, Bak K, Loprinzi CL; American Society of Clinical Oncology.

J Clin Oncol. 2014 Jun 20;32(18):1941-67. doi: 10.1200/JCO.2013.54.0914. Epub 2014 Apr 14. Review.

PMID:
24733808
41.

Phase II trial of neoadjuvant weekly nanoparticle albumin-bound paclitaxel, carboplatin, and biweekly bevacizumab therapy in women with clinical stage II or III HER2-negative breast cancer.

Mrózek E, Layman R, Ramaswamy B, Lustberg M, Vecchione A, Knopp MV, Shapiro CL.

Clin Breast Cancer. 2014 Aug;14(4):228-34. doi: 10.1016/j.clbc.2014.02.005. Epub 2014 Feb 20.

42.

Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients.

Lustberg MB, Balasubramanian P, Miller B, Garcia-Villa A, Deighan C, Wu Y, Carothers S, Berger M, Ramaswamy B, Macrae ER, Wesolowski R, Layman RM, Mrozek E, Pan X, Summers TA, Shapiro CL, Chalmers JJ.

Breast Cancer Res. 2014 Mar 6;16(2):R23. doi: 10.1186/bcr3622.

43.

Genetic validation of the protein arginine methyltransferase PRMT5 as a candidate therapeutic target in glioblastoma.

Yan F, Alinari L, Lustberg ME, Martin LK, Cordero-Nieves HM, Banasavadi-Siddegowda Y, Virk S, Barnholtz-Sloan J, Bell EH, Wojton J, Jacob NK, Chakravarti A, Nowicki MO, Wu X, Lapalombella R, Datta J, Yu B, Gordon K, Haseley A, Patton JT, Smith PL, Ryu J, Zhang X, Mo X, Marcucci G, Nuovo G, Kwon CH, Byrd JC, Chiocca EA, Li C, Sif S, Jacob S, Lawler S, Kaur B, Baiocchi RA.

Cancer Res. 2014 Mar 15;74(6):1752-65. doi: 10.1158/0008-5472.CAN-13-0884. Epub 2014 Jan 22.

44.

Isolation and analysis of rare cells in the blood of cancer patients using a negative depletion methodology.

Wu Y, Deighan CJ, Miller BL, Balasubramanian P, Lustberg MB, Zborowski M, Chalmers JJ.

Methods. 2013 Dec 1;64(2):169-82. doi: 10.1016/j.ymeth.2013.09.006. Epub 2013 Sep 20.

45.

Outcomes of hematopoietic SCT recipients with rhinovirus infection: a matched, case-control study.

Abandeh FI, Lustberg M, Devine S, Elder P, Andritsos L, Martin SI.

Bone Marrow Transplant. 2013 Nov;48(12):1554-7. doi: 10.1038/bmt.2013.100. Epub 2013 Jul 22.

46.

Pilot study on the efficacy of an ondansetron- versus palonosetron-containing antiemetic regimen prior to highly emetogenic chemotherapy.

Wenzell CM, Berger MJ, Blazer MA, Crawford BS, Griffith NL, Wesolowski R, Lustberg MB, Phillips GS, Ramaswamy B, Mrozek E, Flynn JM, Shapiro CL, Layman RM.

Support Care Cancer. 2013 Oct;21(10):2845-51. doi: 10.1007/s00520-013-1865-9. Epub 2013 Jun 8.

47.

Docetaxel-induced skin toxicities in breast cancer patients subsequent to paclitaxel shortage: a case series and literature review.

Poi MJ, Berger M, Lustberg M, Layman R, Shapiro CL, Ramaswamy B, Mrozek E, Olson E, Wesolowski R.

Support Care Cancer. 2013 Oct;21(10):2679-86. doi: 10.1007/s00520-013-1842-3. Epub 2013 May 19.

48.

How much is a life worth? Food for thought.

Lustberg ME, Bauer KA.

Clin Infect Dis. 2013 Aug;57(4):627-8. doi: 10.1093/cid/cit311. Epub 2013 May 8. No abstract available.

49.

Human Vγ2Vδ2 T cells limit breast cancer growth by modulating cell survival-, apoptosis-related molecules and microenvironment in tumors.

Aggarwal R, Lu J, Kanji S, Das M, Joseph M, Lustberg MB, Ray A, Pompili VJ, Shapiro CL, Das H.

Int J Cancer. 2013 Nov;133(9):2133-44. doi: 10.1002/ijc.28217. Epub 2013 May 29.

50.

Beyond the bundle--journey of a tertiary care medical intensive care unit to zero central line-associated bloodstream infections.

Exline MC, Ali NA, Zikri N, Mangino JE, Torrence K, Vermillion B, St Clair J, Lustberg ME, Pancholi P, Sopirala MM.

Crit Care. 2013 Mar 4;17(2):R41. doi: 10.1186/cc12551.

Supplemental Content

Loading ...
Support Center